Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Ranalexin for Sale > Ranalexin 155761-99-2 raw powder High purity 99% Factory supply
Ranalexin 155761-99-2 raw powder High purity 99% Factory supply buy - large image1
Ranalexin 155761-99-2 raw powder High purity 99% Factory supply buy - image1
Ranalexin 155761-99-2 raw powder High purity 99% Factory supply buy - image2
Ranalexin 155761-99-2 raw powder High purity 99% Factory supply buy - image3

Ranalexin 155761-99-2 raw powder High purity 99% Factory supply

Unit Price: Get Latest Price
CAS No.:

155761-99-2

Grade:

Research and Industrial Grade

Content:

98%

Port:

ShangHai

Brand:

Eternal wealth

Packaging:

Plastic bottles

Price valid (until):

2025-04-16

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Semaglutide,Tirzepatide,Retatrutide,Pharmaceutical Peptide,Cosmetic peptide,Custom peptides

  • Product Description

  • Seller Information

  • Description
    Our company is committed to providing high-quality, comprehensive peptide customization services and technical support for domestic and foreign biotechnology companies, research institutes and universities.

    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.
    Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.
    Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.
    Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.


    Remarks: For scientific research or medical use only, not for direct use in humans or as non-medical advice.

    Basic Info
    Product Name:

    Ranalexin

    Other Name:

    Ranalexin;155761-99-2;DTXSID20165963;MFCD00237246;L-Phenylalanyl-L-leucylglycylglycyl-L-leucyl-L-isoleucyl-L-lysyl-L-isoleucyl-L-valyl-L-prolyl-L-alanyl-L-methionyl-L-isoleucyl-L-cysteinyl-L-alanyl-L-valyl-L-threonyl-L-lysyl-L-lystyl-L-cysteine cyclic(14-20)-disulfide;(4R,7S,10S,13S,16S,19S,22R)-22-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-6-amino-2-[[(2S,3S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]acetyl]amino]-4-methylpentanoyl]a;L-Cysteine, L-phenylalanyl-L-leucylglycylglycyl-L-leucyl-L-isoleucyl-L-lysyl-- L-isoleucyl-L-valyl-L-prolyl-L-alanyl-L-methionyl-L-isoleucyl-L-c- ysteinyl-L-alanyl-L-valyl-L-threonyl-L-lysyl-L-lystyl-, cyclic(14-20)-disulfide;L-Cysteine, L-phenylalanyl-L-leucylglycylglycyl-L-leucyl-L-isoleucyl-L-lysyl-L-isoleucyl-L-valyl-L-prolyl-L-alanyl-L-methionyl-L-isoleucyl-L-cysteinyl-L-alanyl-L-valyl-L-threonyl-L-lysyl-L-lystyl-, cyclic(14-20)-disulfide

    CAS No.:

    155761-99-2

    Molecular Formula:

    C97H167N23O22S3

    InChIKeys:

    NSOITZIGPJTCMQ-KCXFZFQESA-N

    Molecular Weight:

    2103.7

    Exact Mass:

    2103.1851724

    DSSTox ID:

    DTXSID20165963

    Categories:

    Polypeptide

    Characteristics

    Hazard Identification

    Classification of the substance or mixture

    no data available

    GHS label elements, including precautionary statements

    Pictogram(s) no data available
    Signal word

    no data available

    Hazard statement(s)

    no data available

    Precautionary statement(s)
    Prevention

    no data available

    Response

    no data available

    Storage

    no data available

    Disposal

    no data available

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Semaglutide,Tirzepatide,Retatrutide,Pharmaceutical Peptide,Cosmetic peptide,Custom peptides

    Location:

    Room 204, Building 2, No. 398 Jinhuan Road, Jinshan District, Shanghai, China

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    11-50

    Year of Establishment:

    2014

    Our company is committed to providing high-quality, comprehensive peptide customization services and technical support for domestic and foreign biotechnology companies, research institutes and universities.
  • Country Product Purchase Quantity Date Posted
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.